Australia markets closed

Iovance Biotherapeutics, Inc. (IOVA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.63+0.75 (+5.82%)
At close: 04:00PM EDT
13.69 +0.06 (+0.44%)
After hours: 07:55PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts12121212
Avg. Estimate-0.42-0.35-1.27-0.71
Low estimate-0.5-0.45-1.8-1.58
High estimate-0.32-0.15-0.470.34
Year ago EPS-0.5-0.47-1.89-1.27
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts12121212
Avg. Estimate2.07M30.43M167.38M418.63M
Low estimate480k5.2M33.2M130.5M
High estimate6M60.6M277.5M744.18M
Year ago sales200k238k1.19M167.38M
Sales growth (year/est)935.00%12,685.70%13,977.40%150.10%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.74-0.8-0.45-0.43
Actual EPS-0.5-0.47-0.46-0.45
Difference0.240.33-0.01-0.02
Surprise %32.40%41.30%-2.20%-4.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.42-0.35-1.27-0.71
7 days ago-0.42-0.36-1.29-0.71
30 days ago-0.42-0.36-1.29-0.71
60 days ago-0.42-0.37-1.34-0.84
90 days ago-0.37-0.35-1.38-0.93
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A11N/A
Up last 30 daysN/A11N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesIOVAIndustrySector(s)S&P 500
Current qtr.16.00%N/AN/AN/A
Next qtr.25.50%N/AN/AN/A
Current year32.80%N/AN/AN/A
Next year44.10%N/AN/AN/A
Next 5 years (per annum)-19.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A